Major study launches to track 2000 leukemia patients for decades
NCT ID NCT06792994
Summary
This study aims to understand what factors influence long-term survival for people with chronic lymphocytic leukemia (CLL). It will follow 2,000 patients who previously received their first treatment in earlier German CLL Study Group trials. The goal is to collect real-world data on survival, quality of life, and later treatments to help doctors make better decisions for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Cologne
Cologne, 50924, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.